Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00035854
Status:
COMPLETED
Last Update Posted:
2009-08-14
First Post:
2002-05-06
Brief Title:
New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria Vancomycin-Resistant Enterococcus
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Linezolid IVPO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children
Status:
COMPLETED
Status Verified Date:
2009-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will treat pediatric patients who have infections that are due to a specific bacteria Vancomycin-Resistant Enterococcus
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A5951062 | None | None | None |